Unleashing neurogenesis

While looking for regulators of neurogenesis, Hongjun Song at Johns Hopkins University School of Medicine and colleagues found that inhibiting the function of the gene disrupted-in-schizophrenia 1 (DISC1) promoted neurogenic behavior.1 The gene is known as a susceptibility gene for mood disorders and schizophrenia, though this was not the focus of Song et al.'s research. They were interested in a previous observation that DISC1 is highly expressed in two areas of the adult brain that

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

While looking for regulators of neurogenesis, Hongjun Song at Johns Hopkins University School of Medicine and colleagues found that inhibiting the function of the gene disrupted-in-schizophrenia 1 (DISC1) promoted neurogenic behavior.1 The gene is known as a susceptibility gene for mood disorders and schizophrenia, though this was not the focus of Song et al.'s research. They were interested in a previous observation that DISC1 is highly expressed in two areas of the adult brain that undergo neurogenesis: the olfactory bulb and the dentate gyrus of the hippocampus.

Because of DISC1's presence in the only brain areas that undergo neurogenesis in the adult, one would have expected that knocking down the gene would inhibit neurogenesis, says Mike Ehlers, a Faculty of 1000 member and professor at Duke University Medical Center. "But you get the opposite here. When you knock it down you get accelerated migration and elaborate morphological aspects" of neurogenesis, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies